Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters

S. Oldenborg, V. Griesdoorn, R. van Os, Y.H. Kusumanto, B.S. Oei, J.L. Venselaar, P.J. Zum Vörde Sive Vörding, M.W. Heymans, M.W. Kolff, C.R.N. Rasch, H. Crezee, G.J. van Tienhoven

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Background/purpose Treatment options for irresectable locoregional recurrent breast cancer in previously irradiated area are limited. Hyperthermia, elevating tumor temperature to 40-45 °C, sensitizes radio-and-chemotherapy. Four hundred and fourteen patients treated with reirradiation + hyperthermia (reRT + HT) in the AMC
Original languageEnglish
Pages (from-to)223-228
JournalRadiotherapy and Oncology
Volume117
Issue number2
DOIs
Publication statusPublished - 2015

Fingerprint

Dive into the research topics of 'Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters'. Together they form a unique fingerprint.

Cite this